View source for West China Hospital apos;s COVID-19 Vaccine Candidate Enters Mid-stage...

<br>BEIJING, Nov 17 (Reuters) - An experimental coronavirus vaccine developed by West China Hospital has entered a mid-stage human test, authorities of China's southwestern province of Sichuan said on Tuesday.<br> <br>A Phase 2 trial to evaluate the safety and ability to trigger immune response of the [http://www.superghostblogger.com/?s=hospital%27s hospital's] candidate, taking place from Nov.<br><br>17, is expected to recruit 960 participants aged older than 18, the Chinese Clinical Trial Registry data showed. website <br>Shanghai Pharmaceuticals Holding , which has invested in a firm jointly developing the vaccine, said on Monday that Phase 1 and Phase 2 trials could complete within this year.<br> <br>The candidate uses coronavirus protein produced in insect cells to trigger immune response, a process that could allow quick and mass production of the vaccine, according to Shanghai Pharma.<br> <br>The technology has been used in developing vaccines against flu and  [https://www.kynghidongduong.vn/blog/kham-pha-lac-son-dai-phat-tuong-thieng-cao-nhat-the-gioi.html kynghidongduong.vn] cervical cancer in Europe and the United States, it said.<br> <br>Participants in the trial will be given two or three doses of the vaccine at different amounts and intervals, or placebo,  [https://www.kynghidongduong.vn/blog/kham-pha-lac-son-dai-phat-tuong-thieng-cao-nhat-the-gioi.html Lạc Sơn Đại Phật] the trial registry record showed.<br> <br>Chinese scientists are leading more than 10 COVID-19 vaccine projects that have entered human tests, and five candidates are undergoing large, final-stage trials overseas.<br><br>(Reporting by Roxanne Liu and Tony Munroe, Editing by William Maclean)<br>